Ask the Experts About Circulating Tumor DNA in the Management of Cancer
Ask the Experts About Circulating Tumor DNA (ctDNA) in the Management of Cancer
Stem Cell Transplant-An Overview for The COVID-19 Era
Stem cell transplant during COVID-19 - how its used to safely treat leukemia, lymphoma, myeloma and other cancers.
Most Frequently Asked Questions about Chemotherapy
Doctors answers to the most frequently asked questions about chemotherapy
Can KRAS Positive Colorectal and Lung Cancer Finally be Targeted?
New precision medicines effectively target KRAS mutations in lung, colon, and other cancers.
Tisotumab Vedotin – Promising in Advanced Cervical Cancer
Novel precision cancer medicine promising for treatment of advanced ovarian cancer.
Checkpoint Inhibitor Immunotherapy for Treatment of Advanced Cervical Cancer
Checkpoint inhibitor immunotherapy prolongs survival and delays recurrence in advanced cervical cancer.
Welcome to CancerConnect
Cancer Connect is a unique resource that brings patients, caregivers, advocates and experts together - individuals benefit from a blend of expert-authored news and educational programming alongside a robust social network, providing insight into symptoms, diagnosis, and treatment and the support of other individuals being treated at some of the best cancer centers. Cancer Connect offers users expert authored clinically-reviewed information and the perspective of their peers in a safe, objective space, helping to ensure they become empowered in their healthcare journey. Search the over 7000 articles on the management of cancer.
Cancer Information Hubs
- Anal
- Bladder
- Bone
- Brain
- Breast
- CUP
- Cervical
- Colon
- Esophageal
- Gastric
- GIST
- Head & Neck
- Hodgkins Lymphoma
- Leukemia
- Liver
- Lung
- Melanoma
- Mesothelioma
- Multiple Myeloma
- Myelodysplastic Syndrome
- MPN
- Neuroblastoma
- Neuroendocrine Tumors
- Non Hodgkins Lymphoma
- Ovarian
- Pancreatic
- Prostate
- Renal
- Rectal
- Sarcoma
- Skin
- Testicular
- Thyroid
- Triple Negative Breast
- Uterine
Newly Diagnosed
Managing a Rare Cancer-What You Need to Know
There are tools—clinical and within ourselves—to help us cope with the challenge of a rare cancer diagnosis.
Tissue Agnostic - Genomic Based Treatment – A Paradigm Shift in Cancer Treatment
FDA Approvals of Rozlytrek, Vitrakvi, Jemperli & other "tissue agnostic" cancers shifts cancer treatment toward genomic testing
Diagnosed With Cancer? A Cancer Recurrence? When to Get a Second Opinion?
An oncologist explains the importance of getting a second opinion following a cancer diagnosis and who should get one
Clinical Trials Are an Integral Part of Cancer Treatment & Should be Considered
Understand how clinical trials are conducted and monitored by the US FDA and local institutional review boards.
Treatment & Care
COVID-19 Vaccines and Cancer-FDA Recommends "Booster"
COVID-19 vaccination answers to frequently asked questions about vaccination and cancer-updated August 12th
Cancer & COVID-19 - What You Need to Know During the "COVID" Era
What you need to know to reduce risks and receive optimal diagnosis and treatment during the COVID-19 pandemic.
Blood Cancers and COVID-19 - What You Need to Know
COCID-19 puts individuals with leukemia, lymphoma, myeloma and MPN's at risk - learn how to optimize your care.
Dietary Supplements and Cancer - What You Need to Know
Understanding dietary supplements - an interview with DrRichard Tsong Lee Director of Integrative Medicine MDACC
Survivorship
COVID-19 Vaccines and Cancer-FDA Recommends "Booster"
COVID-19 vaccination answers to frequently asked questions about vaccination and cancer-updated August 12th
COVID-19 Vaccination in Patients with Blood Cancers
Studies of COVID-19 vaccine effectiveness in myeloma and lymphoma available - vaccine relatively ineffective.
Shingles Vaccine Available for at Risk Individuals & Cancer Patients
Cancer patients should discuss shingles vaccination with their doctor-new Shingrix vaccine highly effective.
Breast Cancer Survival: Coming to Terms with an Uncertain Future
Breast Cancer Survival: Coming to Terms with an Uncertain Future